These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12019709)

  • 1. Orthodontic movement into bone defects augmented with bovine bone mineral and fibrin sealer: a reentry case report.
    Re S; Corrente G; Abundo R; Cardaropoli D
    Int J Periodontics Restorative Dent; 2002 Apr; 22(2):138-45. PubMed ID: 12019709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bio-Oss collagen and orthodontic movement for the treatment of infrabony defects in the esthetic zone.
    Cardaropoli D; Re S; Manuzzi W; Gaveglio L; Cardaropoli G
    Int J Periodontics Restorative Dent; 2006 Dec; 26(6):553-9. PubMed ID: 17243328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2002 Jan; 73(1):123-8. PubMed ID: 11846193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined orthodontic-periodontal treatment in periodontal patients with anteriorly displaced incisors.
    Cao T; Xu L; Shi J; Zhou Y
    Am J Orthod Dentofacial Orthop; 2015 Nov; 148(5):805-13. PubMed ID: 26522041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of open-flap surgery of 32 intrabony defects with and without adjunct bovine bone mineral treatment.
    Slotte C; Asklöw B; Sultan J; Norderyd O
    J Periodontol; 2012 Aug; 83(8):999-1007. PubMed ID: 22166167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects.
    Pietruska MD
    Eur J Oral Sci; 2001 Jun; 109(3):178-81. PubMed ID: 11456348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a bovine bone mineral in periodontal osseous defects: case reports.
    Hutchens LH
    Compend Contin Educ Dent; 1999 Apr; 20(4):365-8, 370, 372-4 passim; quiz 378. PubMed ID: 11692343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of orthodontic intrusive movement to reduce infrabony pockets in adult periodontal patients: a case report.
    Re S; Corrente G; Abundo R; Cardaropoli D
    Int J Periodontics Restorative Dent; 2002 Aug; 22(4):365-71. PubMed ID: 12212683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N
    J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthodontic movement into infrabony defects in patients with advanced periodontal disease: a clinical and radiological study.
    Corrente G; Abundo R; Re S; Cardaropoli D; Cardaropoli G
    J Periodontol; 2003 Aug; 74(8):1104-9. PubMed ID: 14514223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide.
    Camelo M; Nevins ML; Schenk RK; Simion M; Rasperini G; Lynch SE; Nevins M
    Int J Periodontics Restorative Dent; 1998 Aug; 18(4):321-31. PubMed ID: 12693419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrusion of migrated incisors with infrabony defects in adult periodontal patients.
    Cardaropoli D; Re S; Corrente G; Abundo R
    Am J Orthod Dentofacial Orthop; 2001 Dec; 120(6):671-5; quiz 677. PubMed ID: 11742313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the use of a HA/collagen/chondroitin sulphate biomaterial (Biostite) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects.
    Scabbia A; Trombelli L
    J Clin Periodontol; 2004 May; 31(5):348-55. PubMed ID: 15086616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus floor augmentation with bovine hydroxyapatite mixed with fibrin glue and later placement of nonsubmerged implants: a retrospective study in 50 patients.
    Hallman M; Nordin T
    Int J Oral Maxillofac Implants; 2004; 19(2):222-7. PubMed ID: 15101593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.